SPECIAL BULLETIN COVID-19 #25: Emergency Update to NC Medicaid and NC Health Choice Preferred Drug List (PDL) and REMS Program Flexibilities
Author: GDIT, (800) 688-6696
Preferred Drug List (PDL) Update
Effective March 25, 2020, due to drug shortages in the marketplace, the NC Medicaid and NC Health Choice PDL Category of “Respiratory: Beta-Adrenergic Handheld, Short Acting” has changed to the following:
|albuterol HFA inhaler (generic for Proair® HFA Inhaler / Proventil® HFA Inhaler / Ventolin® HFA Inhaler)||levalbuterol HFA inhaler (generic for Xopenex® HFA Inhaler)|
|Proair® HFA Inhaler||Proair® DigihalerTM Inhaler|
|Proair® RespiClick® Inhaler|
|Proventil® HFA Inhaler|
|Ventolin® HFA Inhaler|
|Xopenex® HFA Inhaler|
Please visit the following site for a full PDL listing: https://medicaid.ncdhhs.gov/documents/preferred-drug-list
Updated Guidance for REMS Requirements
NC Medicaid would like to share information about recent FDA guidance regarding REMS requirements during the COVID-19 public health emergency.
Please visit https://www.fda.gov/media/136317/download for the current recommendations.